These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9876589)

  • 21. Physical properties of the complexes formed between heptakis(2,6-di-O-methyl)-beta-cyclodextrin, beta-cyclodextrin, and chlorambucil.
    Green AR; Miller ES; Guillory JK
    J Pharm Sci; 1991 Feb; 80(2):186-9. PubMed ID: 2051328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase solubility and inclusion complex of itraconazole with beta-cyclodextrin using supercritical carbon dioxide.
    Al-Marzouqi AH; Shehatta I; Jobe B; Dowaidar A
    J Pharm Sci; 2006 Feb; 95(2):292-304. PubMed ID: 16372306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
    Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
    Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary systems.
    Veiga F; Fernandes C; Maincent P
    Drug Dev Ind Pharm; 2001 Jul; 27(6):523-32. PubMed ID: 11548859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 2-hydroxypropyl-beta-cyclodextrin on crystallization and polymorphic transition of nifedipine in solid state.
    Hirayama F; Wang Z; Uekama K
    Pharm Res; 1994 Dec; 11(12):1766-70. PubMed ID: 7899242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 1. Allopurinol.
    Ammar HO; el-Nahhas SA
    Pharmazie; 1995 Jan; 50(1):49-51. PubMed ID: 7886125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased shelf-life of fosphenytoin: solubilization of a degradant, phenytoin, through complexation with (SBE)7m-beta-CD.
    Narisawa S; Stella VJ
    J Pharm Sci; 1998 Aug; 87(8):926-30. PubMed ID: 9687335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of surfactants (present in the dissolution media) on the release behaviour of tolbutamide from its inclusion complex with beta-cyclodextrin.
    Veiga MD; Ahsan F
    Eur J Pharm Sci; 2000 Jan; 9(3):291-9. PubMed ID: 10594387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
    Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations.
    Villaverde J; Morillo E; Pérez-Martínez JI; Ginés JM; Maqueda C
    J Agric Food Chem; 2004 Feb; 52(4):864-9. PubMed ID: 14969543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cyclodextrins on the solubility and stability of candesartan cilexetil in solution and solid state.
    Al Omari AA; Al Omari MM; Badwan AA; Al-Sou'od KA
    J Pharm Biomed Anal; 2011 Feb; 54(3):503-9. PubMed ID: 20971593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct compression tablets containing a series of four beta-cyclodextrin complexes formed by neutralizing an acidic drug.
    Moore E; Bergamo R; Casella R
    Drug Dev Ind Pharm; 2000 Dec; 26(12):1259-70. PubMed ID: 11147126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
    Lin SY; Hsu CH; Sheu MT
    J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.
    Zingone G; Rubessa F
    Int J Pharm; 2005 Mar; 291(1-2):3-10. PubMed ID: 15707726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of dissolution properties of a new Helicobacter pylori eradicating agent (TG44) by inclusion complexation with beta-cyclodextrin.
    Anzai K; Mizoguchi J; Yanagi T; Hirayama F; Arima H; Uekama K
    Chem Pharm Bull (Tokyo); 2007 Oct; 55(10):1466-70. PubMed ID: 17917290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
    Chen JY; Tsai WY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
    Ozdemir N; Ordu S
    Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
    Koontz JL; Marcy JE
    J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ternary inclusion complex formation and stabilization of limaprost, a prostaglandin E1 derivative, in the presence of α- and β-cyclodextrins in the solid state.
    Inoue Y; Iohara D; Sekiya N; Yamamoto M; Ishida H; Sakiyama Y; Hirayama F; Arima H; Uekama K
    Int J Pharm; 2016 Jul; 509(1-2):338-347. PubMed ID: 27286633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissolution properties of praziquantel-beta-cyclodextrin systems.
    el-Arini SK; Leuenberger H
    Pharm Dev Technol; 1996 Oct; 1(3):307-15. PubMed ID: 9552314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.